Novel Drug Approvals for 2020

No Drug Active Approval FDA-approved use on approval

. Name Ingredient Date date*

40. Gavreto pralsetinib 9/4/2020 To treat non-small lung cancer

Drug Trials Snapshot

39. Detectnet copper Cu 64 9/3/2020 To help detect certain types of

dotatate neuroendocrine tumors
injection Drug Trials Snapshot

38. Sogroya somapacitan- 8/28/2020 Growth hormone

beco Drug Trials Snapshot

37. Winlevi clascoterone 8/26/2020 To treat acne

Drug Trials Snapshot

36. Enspryng satralizumab- 8/14/2020 To treat neuromyelitis optica

mwge spectrum disorder
Press Release
Drug Trials Snapshot

35. Viltepso viltolarsen 8/12/2020 To treat Duchenne muscular

dystrophy
Press Release
Drug Trials Snapshot

34. Olinvyk oliceridine 8/7/2020 To manage acute pain in certain

adults
Press Release
No Drug Active Approval FDA-approved use on approval
. Name Ingredient Date date*

Drug Trials Snapshot

33. Evrysdi risdiplam 8/7/2020 To treat spinal muscular atrophy

Press Release
Drug Trials Snapshot

32. Lampit nifurtimox 8/6/2020 To treat Chagas disease in certain

pediatric patients younger than age
18
Drug Trials Snapshot

31. Blenrep belantamab 8/5/2020 To treat multiple myeloma

mafodotin-blmf) Drug Trials Snapshot

30. Monjuvi tafasitamab-cxix 7/31/2020 To treat relapsed or refractory

diffuse large B-cell lymphoma
Drug Trials Snapshot

29. Xeglyze abametapir 7/24/2020 To treat head lice

Drug Trials Snapshot

28. Inqovi decitabine and 7/7/2020 To treat adult patients with

cedazuridine myelodysplastic syndromes
Drug Trials Snapshot
No Drug Active Approval FDA-approved use on approval
. Name Ingredient Date date*

To treat HIV
Press Release
27. Rukobia fostemsavir 7/2/2020
Drug Trials Snapshot

26. Byfavo remimazolam 7/2/2020 For sedation

Drug Trials Snapshot

25. Dojolvi triheptanoin 6/30/2020 To treat molecularly long-chain fatty

acid oxidation disorders
Drug Trials Snapshot

24. Zepzelca lurbinectedin 6/15/2020 To treat metastatic small cell lung

cancer
Drug Trials Snapshot

23, Uplizna inebilizumab- 6/11/2020 To treat neuromyelitis optica

cdon spectrum disorder
Press Release
Drug Trials Snapshot

22. Tauvid flortaucipir F18 5/28/2020 Diagnostic agent for patients with
Alzheimer’s disease
Press Release
Drug Trials Snapshot

21. Artesunate artesunate 5/26/2020 To treat severe malaria

Press Release

20. Cerianna fluoroestrdiol 5/20/2020 Diagnostic imaging agent for certain

F18 patients with breast cancer
Drug Trials Snapshot

19. Qinlock ripretinib 5/15/2020 To treat advanced gastrointestinal-

stromal tumors
Press Release
Drug Trials Snapshot

18. Retevmo selpercatinib 5/8/2020 To treat lung and thyroid cancers

Press Release
Drug Trials Snapshot

17. Tabrecta capmatinib 5/6/2020 To treat patients with non small cell
lung cancer
Press Release
Drug Trials Snapshot

16. Ongentys opicapone 4/24/2020 To treat patients with Parkinson’s

disease experiencing “off” episodes
No Drug Active Approval FDA-approved use on approval
. Name Ingredient Date date*

Drug Trials Snapshot

15. Trodelvy sacituzumab 4/22/2020 To treat adult patients with

govitecan-hziy metastatic triple-negative breast
cancer who received at least two
prior therapies for metastatic
disease
Press Release
Drug Trials Snapshot

14. Pemazyre pemigatinib 4/17/2020 To treat certain patients with

cholangiocarcinoma, a rare form of
cancer that forms in bile ducts
Press Release
Drug Trials Snapshot

13. Tukysa tucatinib 4/17/2020 To treat advanced unresectable or

metastatic HER2-positive breast
cancer
Drug Trials Snapshot

12. Koselugo selumetinib 4/10/2020 To treat neurofibromatosis type 1, a

genetic disorder of the nervous
system causing tumors to grow on
nerves
Drug Trials Snapshot

11. Zeposia ozanimod 3/25/2020 To treat relapsing forms of multiple

sclerosis
Drug Trials Snapshot

10. Isturisa osilodrostat 3/6/2020 To treat adults with Cushing’s

disease who either cannot undergo
pituitary gland surgery or have
undergone the surgery but still have
the disease
Press Release
Drug Trials Snapshot

9. Sarclisa isatuximab 3/2/2020 To treat multiple myloma

Press Release
Drug Trials Snapshot

8. Nurtec rimegepant 2/27/2020 To treat migraine

ODT Drug Trials Snapshot

7. Barhemsy amisulpride 2/26/2020 To help prevent nausea and

s vomiting after surgery
Drug Trial Snapshot
No Drug Active Approval FDA-approved use on approval
. Name Ingredient Date date*

6. Vyepti eptinezumab- 2/21/2020 For the preventive treatment of

jjmr migraine in adults
Drug Trials Snapshot

5. Nexletol bempedoic acid 2/21/2020 To treat adults with heterozygous

familial hypercholesterolemia or
established atherosclerotic
cardiovascular disease who require
additional lowering of LDL-C
Drug Trials Snapshot

4. Pizensy lactitol 2/12/2020 To treat chronic idiopathic

constipation (CIC) in adults
Drug Trials Snapshot

3. Tazverik tazemetostat 1/23/2020 To treat epithelioid sarcoma

Press Release
Drug Trials Snapshot

2. Tepezza teprotumumab- 1/21/2020 To treat Thyroid eye disease

trbw Press Release
Drug Trials Snapshot

1. Ayvakit avapritinib 1/9/2020 To treat adults with unresectable or

metastatic gastrointestinal stromal
tumor (GIST)
FDA Information
Drug Trials Snapshot